Topics & People

Advanced medical treatments modifying genes or using cells to rejuvenate the body.

Former director of the National Institute of Allergy and Infectious Diseases, mentioned as part of the old guard and culture at the NIH.

The community of microorganisms in the body, which was altered positively by psilocybin use.

A category of non-prescription medications. The FDA aims to move more drugs into this category to increase price transparency, competition, and access while bypassing PBMs.

Generic versions of biologic drugs. The FDA is cutting the red tape for their approval to increase competition and lower drug prices.

A class of expensive medications manufactured using a cell line. The FDA is working to lower their prices by accelerating the approval of their generic equivalents, biosimilars.

A policy pursued by the Trump administration to ensure the US pays the lowest price for pharmaceuticals among developed nations, aiming to radically lower drug costs.

Centers for Disease Control and Prevention.

A new, smaller, and prioritized list of recommended childhood vaccines (38 doses) created by the FDA to rebuild public trust and combat vaccine hesitancy.

A physiological condition, often driven by high carbohydrate intake, that is at the root of most chronic diseases like diabetes and heart disease.

A major public health crisis in the United States, with 40-60% of the adult population being clinically obese. It's being addressed by both dietary changes and new drugs like GLP-1s.

A class of food products that have been stripped of fiber and nutrients, identified as a primary driver of the obesity and diabetes epidemics in American children.